| P3R | Name: | (5~{R})-7,8-dimethoxy-3,5-dimethyl-2,5-dihydro-1~{H}-3-benzazepin-4-one | Formula: | C14 H19 N O3 | SMILES: | COc1cc2CCN(C)C(=O)[CH](C)c2cc1OC | InChi: | InChI=1S/C14H19NO3/c1-9-11-8-13(18-4)12(17-3)7-10(11)5-6-15(2)14(9)16/h7-9H,5-6H2,1-4H3/t9-/m1/s1 | Definition date: | 2022-09-30 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | (5~{R})-7,8-dimethoxy-3,5-dimethyl-2,5-dihydro-1~{H}-3-benzazepin-4-one |
|
| P4M | Name: | 7,8-dimethoxy-3-methyl-1~{H}-3-benzazepin-2-one | Formula: | C13 H15 N O3 | SMILES: | COc1cc2CC(=O)N(C)C=Cc2cc1OC | InChi: | InChI=1S/C13H15NO3/c1-14-5-4-9-6-11(16-2)12(17-3)7-10(9)8-13(14)15/h4-7H,8H2,1-3H3 | Synonyms: | 7,8-dimethoxy-3-methyl-1,3-dihydro-2H-benzo[d]azepin-2-one | Definition date: | 2022-09-30 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | 7,8-dimethoxy-3-methyl-1~{H}-3-benzazepin-2-one |
|
| P4X | Name: | (1~{R})-7-[(1~{R})-1,2-bis(oxidanyl)ethyl]-1,3-dimethyl-5-(1-methylpyrazol-4-yl)-1~{H}-3-benzazepin-2-one | Formula: | C18 H21 N3 O3 | SMILES: | C[CH]1C(=O)N(C)C=C(c2cnn(C)c2)c3cc(ccc13)[CH](O)CO | InChi: | InChI=1S/C18H21N3O3/c1-11-14-5-4-12(17(23)10-22)6-15(14)16(9-20(2)18(11)24)13-7-19-21(3)8-13/h4-9,11,17,22-23H,10H2,1-3H3/t11-,17+/m1/s1 | Definition date: | 2022-09-30 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | (1~{R})-7-[(1~{R})-1,2-bis(oxidanyl)ethyl]-1,3-dimethyl-5-(1-methylpyrazol-4-yl)-1~{H}-3-benzazepin-2-one |
|
| NWX | Name: | [[(2~{R},3~{S},4~{R},5~{R})-5-(4-azanylpyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate | Formula: | C12 H16 N5 O13 P3 | SMILES: | Nc1ncnn2c1ccc2[C]3(O[CH](CO[P](O)(=O)O[P](O)(=O)O[P](O)(O)=O)[CH](O)[CH]3O)C#N | InChi: | InChI=1S/C12H16N5O13P3/c13-4-12(8-2-1-6-11(14)15-5-16-17(6)8)10(19)9(18)7(28-12)3-27-32(23,24)30-33(25,26)29-31(20,21)22/h1-2,5,7,9-10,18-19H,3H2,(H,23,24)(H,25,26)(H2,14,15,16)(H2,20,21,22)/t7-,9-,10-,12+/m1/s1 | Synonyms: | Remdesivir triphosphate | Definition date: | 2022-04-13 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | [[(2~{R},3~{S},4~{R},5~{R})-5-(4-azanylpyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate |
|
| QIJ | Name: | 4-amino-8-methylpteridine-2,7(1H,8H)-dione | Formula: | C7 H7 N5 O2 | SMILES: | O=C1NC2=C(N=CC(=O)N2C)C(N)=N1 | InChi: | InChI=1S/C7H7N5O2/c1-12-3(13)2-9-4-5(8)10-7(14)11-6(4)12/h2H,1H3,(H3,8,10,11,14) | Definition date: | 2022-06-12 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | 4-amino-8-methylpteridine-2,7(1H,8H)-dione |
|
| JKR | Name: | 3-[5-[3-bis(oxidanyl)phosphanyloxypropoxy]naphthalen-1-yl]oxypropyl 3-(5-oxidanylnaphthalen-1-yl)oxypropyl hydrogen phosphate | Formula: | C29 H34 O11 P2 | SMILES: | OP(O)OCCCOc1cccc2c(OCCCO[P](O)(=O)OCCCOc3cccc4c(O)cccc34)cccc12 | InChi: | InChI=1S/C29H34O11P2/c30-26-12-1-9-23-22(26)8-2-13-27(23)36-17-6-20-39-42(33,34)40-21-7-18-37-29-15-4-10-24-25(29)11-3-14-28(24)35-16-5-19-38-41(31)32/h1-4,8-15,30-32H,5-7,16-21H2,(H,33,34) | Definition date: | 2022-05-04 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | 3-[5-[3-bis(oxidanyl)phosphanyloxypropoxy]naphthalen-1-yl]oxypropyl 3-(5-oxidanylnaphthalen-1-yl)oxypropyl hydrogen phosphate |
|
| JL0 | Name: | 3-[13-methyl-5,7,12,14-tetrakis(oxidanylidene)-6,13-diazatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(15),2,4(16),8,10-pentaen-6-yl]propyl 3-[5,7,12,14-tetrakis(oxidanylidene)-13-(3-oxidanylpropyl)-6,13-diazatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1,3,8(16),9,11(15)-pentaen-6-yl]propyl hydrogen phosphate | Formula: | C43 H43 N4 O21 P3 | SMILES: | OCCCO[P](O)(=O)OCCCN1C(=O)c2ccc3C(=O)N(CCCO[P](O)(=O)OCCCN4C(=O)c5ccc6C(=O)N(CCCO[P](O)(O)=O)C(=O)c7ccc(C4=O)c5c67)C(=O)c8ccc(C1=O)c2c38 | InChi: | InChI=1S/C43H43N4O21P3/c48-18-5-23-68-71(62,63)67-22-4-17-47-42(55)30-12-10-28-34-29(11-13-31(35(30)34)43(47)56)41(54)46(40(28)53)16-3-21-66-70(60,61)65-20-2-15-45-38(51)26-8-6-24-32-25(7-9-27(33(26)32)39(45)52)37(50)44(36(24)49)14-1-19-64-69(57,58)59/h6-13,48H,1-5,14-23H2,(H,60,61)(H,62,63)(H2,57,58,59) | Definition date: | 2022-05-04 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | 3-oxidanylpropyl 3-[5,7,12,14-tetrakis(oxidanylidene)-13-[3-[oxidanyl-[3-[5,7,12,14-tetrakis(oxidanylidene)-13-(3-phosphonooxypropyl)-6,13-diazatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1,3,8(16),9,11(15)-pentaen-6-yl]propoxy]phosphoryl]oxypropyl]-6,13-diazatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(15),2,4(16),8,10-pentaen-6-yl]propyl hydrogen phosphate |
|
| KV0 | Name: | 4-(3-fluoranylpyrrol-1-yl)-3,5-bis(iodanyl)-2-oxidanyl-benzoic acid | Formula: | C11 H6 F I2 N O3 | SMILES: | OC(=O)c1cc(I)c(n2ccc(F)c2)c(I)c1O | InChi: | InChI=1S/C11H6FI2NO3/c12-5-1-2-15(4-5)9-7(13)3-6(11(17)18)10(16)8(9)14/h1-4,16H,(H,17,18) | Definition date: | 2022-06-07 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | 4-(3-fluoranylpyrrol-1-yl)-3,5-bis(iodanyl)-2-oxidanyl-benzoic acid |
|
| KVA | Name: | 4-[3,4-bis(fluoranyl)pyrrol-1-yl]-3,5-bis(iodanyl)-2-oxidanyl-benzoic acid | Formula: | C11 H5 F2 I2 N O3 | SMILES: | OC(=O)c1cc(I)c(n2cc(F)c(F)c2)c(I)c1O | InChi: | InChI=1S/C11H5F2I2NO3/c12-5-2-16(3-6(5)13)9-7(14)1-4(11(18)19)10(17)8(9)15/h1-3,17H,(H,18,19) | Definition date: | 2022-06-07 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | 4-[3,4-bis(fluoranyl)pyrrol-1-yl]-3,5-bis(iodanyl)-2-oxidanyl-benzoic acid |
|
| QAX | Name: | 6-methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-ol | Formula: | C17 H23 N3 O3 | SMILES: | Oc1ncnc2cc(OCCCN3CCCCC3)c(OC)cc21 | InChi: | InChI=1S/C17H23N3O3/c1-22-15-10-13-14(18-12-19-17(13)21)11-16(15)23-9-5-8-20-6-3-2-4-7-20/h10-12H,2-9H2,1H3,(H,18,19,21) | Definition date: | 2022-06-05 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | 6-methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-ol |
|
| QB3 | Name: | 6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-ol | Formula: | C16 H21 N3 O3 | SMILES: | CN1CCC(COc2cc3ncnc(O)c3cc2OC)CC1 | InChi: | InChI=1S/C16H21N3O3/c1-19-5-3-11(4-6-19)9-22-15-8-13-12(7-14(15)21-2)16(20)18-10-17-13/h7-8,10-11H,3-6,9H2,1-2H3,(H,17,18,20) | Definition date: | 2022-06-05 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | 6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-ol |
|
| E0X | Name: | ~{N}-[4-(2-azanyl-3-chloranyl-pyridin-4-yl)oxy-3-fluoranyl-phenyl]-5-(4-fluorophenyl)-4-oxidanylidene-1~{H}-pyridine-3-carboxamide | Formula: | C23 H15 Cl F2 N4 O3 | SMILES: | Nc1nccc(Oc2ccc(NC(=O)C3=CNC=C(C3=O)c4ccc(F)cc4)cc2F)c1Cl | InChi: | InChI=1S/C23H15ClF2N4O3/c24-20-19(7-8-29-22(20)27)33-18-6-5-14(9-17(18)26)30-23(32)16-11-28-10-15(21(16)31)12-1-3-13(25)4-2-12/h1-11H,(H2,27,29)(H,28,31)(H,30,32) | Definition date: | 2022-04-16 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | ~{N}-[4-(2-azanyl-3-chloranyl-pyridin-4-yl)oxy-3-fluoranyl-phenyl]-5-(4-fluorophenyl)-4-oxidanylidene-1~{H}-pyridine-3-carboxamide |
|
| G2E | Name: | (7~{R})-1'-pentylspiro[6~{H}-furo[3,2-f][1,3]benzodioxole-7,3'-indole]-2'-one | Formula: | C21 H21 N O4 | SMILES: | CCCCCN1C(=O)[C]2(COc3cc4OCOc4cc23)c5ccccc15 | InChi: | InChI=1S/C21H21NO4/c1-2-3-6-9-22-16-8-5-4-7-14(16)21(20(22)23)12-24-17-11-19-18(10-15(17)21)25-13-26-19/h4-5,7-8,10-11H,2-3,6,9,12-13H2,1H3/t21-/m1/s1 | Definition date: | 2022-05-03 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | (7~{R})-1'-pentylspiro[6~{H}-furo[3,2-f][1,3]benzodioxole-7,3'-indole]-2'-one |
|
| G2W | Name: | 3-[[4-[3-(4-fluoranyl-2-methyl-phenoxy)azetidin-1-yl]pyrimidin-2-yl]amino]-~{N}-methyl-benzamide | Formula: | C22 H22 F N5 O2 | SMILES: | CNC(=O)c1cccc(Nc2nccc(n2)N3CC(C3)Oc4ccc(F)cc4C)c1 | InChi: | InChI=1S/C22H22FN5O2/c1-14-10-16(23)6-7-19(14)30-18-12-28(13-18)20-8-9-25-22(27-20)26-17-5-3-4-15(11-17)21(29)24-2/h3-11,18H,12-13H2,1-2H3,(H,24,29)(H,25,26,27) | Definition date: | 2022-05-03 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | 3-[[4-[3-(4-fluoranyl-2-methyl-phenoxy)azetidin-1-yl]pyrimidin-2-yl]amino]-~{N}-methyl-benzamide |
|
| G4I | Name: | (1~{Z})-~{N}-[2-methyl-3-[(~{E})-[6-[4-[[4-(trifluoromethyloxy)phenyl]methoxy]piperidin-1-yl]-1~{H}-1,3,5-triazin-2-ylidene]amino]phenyl]ethanimidic acid | Formula: | C25 H27 F3 N6 O3 | SMILES: | CC(O)=Nc1cccc(N=C2NC(=NC=N2)N3CCC(CC3)OCc4ccc(OC(F)(F)F)cc4)c1C | InChi: | InChI=1S/C25H27F3N6O3/c1-16-21(31-17(2)35)4-3-5-22(16)32-23-29-15-30-24(33-23)34-12-10-19(11-13-34)36-14-18-6-8-20(9-7-18)37-25(26,27)28/h3-9,15,19H,10-14H2,1-2H3,(H,31,35)(H,29,30,32,33) | Definition date: | 2022-05-03 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | (1~{Z})-~{N}-[2-methyl-3-[(~{E})-[6-[4-[[4-(trifluoromethyloxy)phenyl]methoxy]piperidin-1-yl]-1~{H}-1,3,5-triazin-2-ylidene]amino]phenyl]ethanimidic acid |
|
| 554 | Name: | (2~{S})-1-[(3~{S})-3-[[(3~{S})-3,4-bis(oxidanyl)-4-oxidanylidene-butyl]amino]-4-oxidanyl-4-oxidanylidene-butyl]azetidine-2-carboxylic acid | Formula: | C12 H20 N2 O7 | SMILES: | O[CH](CCN[CH](CCN1CC[CH]1C(O)=O)C(O)=O)C(O)=O | InChi: | InChI=1S/C12H20N2O7/c15-9(12(20)21)1-4-13-7(10(16)17)2-5-14-6-3-8(14)11(18)19/h7-9,13,15H,1-6H2,(H,16,17)(H,18,19)(H,20,21)/t7-,8-,9-/m0/s1 | Definition date: | 2022-02-02 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | (2~{S})-1-[(3~{S})-3-[[(3~{S})-3,4-bis(oxidanyl)-4-oxidanylidene-butyl]amino]-4-oxidanyl-4-oxidanylidene-butyl]azetidine-2-carboxylic acid |
|
| 5ZS | Name: | (2~{S})-1-[(3~{S})-3-[[(3~{S})-3,4-bis(oxidanyl)-4-oxidanylidene-butyl]amino]-4-oxidanyl-4-oxidanylidene-butyl]pyrrolidine-2-carboxylic acid | Formula: | C13 H22 N2 O7 | SMILES: | O[CH](CCN[CH](CCN1CCC[CH]1C(O)=O)C(O)=O)C(O)=O | InChi: | InChI=1S/C13H22N2O7/c16-10(13(21)22)3-5-14-8(11(17)18)4-7-15-6-1-2-9(15)12(19)20/h8-10,14,16H,1-7H2,(H,17,18)(H,19,20)(H,21,22)/t8-,9-,10-/m0/s1 | Definition date: | 2022-02-08 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | (2~{S})-1-[(3~{S})-3-[[(3~{S})-3,4-bis(oxidanyl)-4-oxidanylidene-butyl]amino]-4-oxidanyl-4-oxidanylidene-butyl]pyrrolidine-2-carboxylic acid |
|
| 9W9 | Name: | 3-oxidanylbenzenecarbonitrile | Formula: | C7 H5 N O | SMILES: | Oc1cccc(c1)C#N | InChi: | InChI=1S/C7H5NO/c8-5-6-2-1-3-7(9)4-6/h1-4,9H | Synonyms: | Darunavir | Definition date: | 2021-11-22 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | 3-oxidanylbenzenecarbonitrile |
|
| A7X | Name: | 4-[(E)-(6-azanyl-1-methyl-2-oxidanylidene-indol-3-ylidene)methyl]benzoic acid | Formula: | C17 H14 N2 O3 | SMILES: | CN1C(=O)C(=Cc2ccc(cc2)C(O)=O)c3ccc(N)cc13 | InChi: | InChI=1S/C17H14N2O3/c1-19-15-9-12(18)6-7-13(15)14(16(19)20)8-10-2-4-11(5-3-10)17(21)22/h2-9H,18H2,1H3,(H,21,22)/b14-8+ | Synonyms: | (E)-4-((6-amino-1-methyl-2-oxoindolin-3-ylidene)methyl)benzoic acid | Definition date: | 2021-11-25 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | 4-[(~{E})-(6-azanyl-1-methyl-2-oxidanylidene-indol-3-ylidene)methyl]benzoic acid |
|
| AI0 | Name: | 1-(8-oxidanylquinolin-2-yl)-N-(phenylmethyl)methanimine oxide | Formula: | C17 H14 N2 O2 | SMILES: | Oc1cccc2ccc(C=[N+]([O-])Cc3ccccc3)nc12 | InChi: | InChI=1S/C17H14N2O2/c20-16-8-4-7-14-9-10-15(18-17(14)16)12-19(21)11-13-5-2-1-3-6-13/h1-10,12,20H,11H2/b19-12- | Synonyms: | (Z)-N-benzyl-1-(8-hydroxyquinolin-2-yl)methanimine oxide | Definition date: | 2021-11-26 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | 1-(8-oxidanylquinolin-2-yl)-~{N}-(phenylmethyl)methanimine oxide |
|
| AI6 | Name: | N-tert-butyl-1-[8-[3-(4-prop-2-ynylpiperazin-1-yl)propoxy]quinolin-2-yl]methanimine oxide | Formula: | C24 H32 N4 O2 | SMILES: | CC(C)(C)[N+]([O-])=Cc1ccc2cccc(OCCCN3CCN(CC3)CC#C)c2n1 | InChi: | InChI=1S/C24H32N4O2/c1-5-12-26-14-16-27(17-15-26)13-7-18-30-22-9-6-8-20-10-11-21(25-23(20)22)19-28(29)24(2,3)4/h1,6,8-11,19H,7,12-18H2,2-4H3/b28-19- | Synonyms: | (Z)-N-tert-butyl-1-(8-(3-(4-(prop-2-yn-1-yl)piperazin-1-yl)propoxy)quinolin-2-yl)methanimine oxide | Definition date: | 2021-11-26 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | ~{N}-~{tert}-butyl-1-[8-[3-(4-prop-2-ynylpiperazin-1-yl)propoxy]quinolin-2-yl]methanimine oxide |
|
| 5I0 | Name: | [(2~{S},3~{S},4~{S},5~{R},6~{S})-2-[(2~{R},3~{R},4~{R},5~{S})-2-[(1~{R},2~{S},3~{R},4~{R},5~{S},6~{R})-2,4-bis[[azaniumylidene(azanyl)methyl]amino]-3,5,6-tris(oxidanyl)cyclohexyl]oxy-4-[bis(oxidanyl)methyl]-5-methyl-4-oxidanyl-oxolan-3-yl]oxy-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-3-yl]-methyl-azanium | Formula: | C21 H44 N7 O13 | SMILES: | C[NH2+][CH]1[CH](O)[CH](O)[CH](CO)O[CH]1O[CH]2[CH](O[CH](C)[C]2(O)C(O)O)O[CH]3[CH](O)[CH](O)[CH](NC(N)=[NH2+])[CH](O)[CH]3NC(N)=[NH2+] | InChi: | InChI=1S/C21H41N7O13/c1-4-21(37,18(35)36)15(41-16-8(26-2)12(33)9(30)5(3-29)39-16)17(38-4)40-14-7(28-20(24)25)10(31)6(27-19(22)23)11(32)13(14)34/h4-18,26,29-37H,3H2,1-2H3,(H4,22,23,27)(H4,24,25,28)/p+3/t4-,5-,6+,7-,8-,9-,10+,11-,12-,13+,14+,15-,16-,17-,21+/m0/s1 | Synonyms: | hydrated form of streptomycin | Definition date: | 2021-07-09 | Last modified: | 2022-11-23 | Release date: | 2022-07-27 | Identifier: | [(2~{S},3~{S},4~{S},5~{R},6~{S})-2-[(2~{R},3~{R},4~{R},5~{S})-2-[(1~{R},2~{S},3~{R},4~{R},5~{S},6~{R})-2,4-bis[[azaniumylidene(azanyl)methyl]amino]-3,5,6-tris(oxidanyl)cyclohexyl]oxy-4-[bis(oxidanyl)methyl]-5-methyl-4-oxidanyl-oxolan-3-yl]oxy-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-3-yl]-methyl-azanium |
|
| OG3 | Name: | (1~{R})-1-(4-chlorophenyl)ethanamine | Formula: | C8 H10 Cl N | SMILES: | C[CH](N)c1ccc(Cl)cc1 | InChi: | InChI=1S/C8H10ClN/c1-6(10)7-2-4-8(9)5-3-7/h2-6H,10H2,1H3/t6-/m1/s1 | Synonyms: | (R)-1-(4-chlorophenyl)ethan-1-amine | Definition date: | 2022-09-07 | Last modified: | 2022-11-18 | Release date: | 2022-11-23 | Identifier: | (1~{R})-1-(4-chlorophenyl)ethanamine |
|
| U9P | Name: | (5M)-N-methyl-5-{(6M,8S)-5-{[(3S)-oxolan-3-yl]amino}-6-[1-(propan-2-yl)-1H-pyrazol-3-yl]pyrazolo[1,5-a]pyrimidin-3-yl}pyridine-3-carboxamide | Formula: | C23 H26 N8 O2 | SMILES: | CC(C)n1ccc(n1)c1cn2ncc(c2nc1NC1CCOC1)c1cc(cnc1)C(=O)NC | InChi: | InChI=1S/C23H26N8O2/c1-14(2)30-6-4-20(29-30)19-12-31-22(28-21(19)27-17-5-7-33-13-17)18(11-26-31)15-8-16(10-25-9-15)23(32)24-3/h4,6,8-12,14,17H,5,7,13H2,1-3H3,(H,24,32)(H,27,28)/t17-/m0/s1 | Definition date: | 2022-08-12 | Last modified: | 2022-11-18 | Release date: | 2022-11-23 | Identifier: | (5M)-N-methyl-5-{(6M,8S)-5-{[(3S)-oxolan-3-yl]amino}-6-[1-(propan-2-yl)-1H-pyrazol-3-yl]pyrazolo[1,5-a]pyrimidin-3-yl}pyridine-3-carboxamide |
|
| WUW | Name: | (1R,4R,5R,6S)-2-(methanesulfonyl)-4,6-dimethoxy-2-azabicyclo[3.3.1]nonane | Formula: | C11 H21 N O4 S | SMILES: | CS(=O)(=O)N1CC(OC)C2CC1CCC2OC | InChi: | InChI=1S/C11H21NO4S/c1-15-10-5-4-8-6-9(10)11(16-2)7-12(8)17(3,13)14/h8-11H,4-7H2,1-3H3/t8-,9-,10+,11+/m1/s1 | Definition date: | 2022-10-20 | Last modified: | 2022-11-18 | Release date: | 2022-11-23 | Identifier: | (1R,4R,5R,6S)-2-(methanesulfonyl)-4,6-dimethoxy-2-azabicyclo[3.3.1]nonane |
|